15 Oct 2013 15:14
15 October 2013
Plethora Solutions Holdings PLC
("Plethora" or the "Company")
Exercise of warrant
Plethora Solutions Holdings plc (AIM: PLE) announces that it has received notice from the holder of a warrant to subscribe for 410,000 shares at 10p per share to exercise that warrant.
Application has been made to the London Stock Exchange for the shares arising from the exercise to be admitted to trading. Dealings in the new shares are expected to commence on 21 October 2013.
-Ends-
Enquiries:
Plethora Solutions Ronald Openshaw, CEO | Tel : +44(0) 20 3077 5400 |
Daniel Stewart (Nomad & Joint Broker) David Hart / Ciaran Walsh (Nomad) Martin Lampshire (Broker) | Tel : +44(0) 20 7776 6550
|
Hybridan LLP (Joint Broker) Claire Louise Noyce William Lynne |
Tel: +44(0) 20 7947 4350 Tel: +44(0) 20 7947 4361
|
Britton Financial PR Tim Blackstone | Tel: + 44 (0) 20 7242 9786 +44 (0) 7957 140416 |
About Plethora:
Plethora is headquartered in the UK and is listed on the London Stock Exchange (AIM: PLE.L). Further information is available at www.plethorasolutions.co.uk
Plethora is focussed on seeking to launchPSD502 for the treatment of premature ejaculation.
Plethora Solutions Holdings Plc (PLE)